Pediatric Cefuroxime IV Dosing Recommendations
Dosing Guidelines by Age and Indication
- The recommended intravenous (IV) dosage of cefuroxime for pediatric patients is 100-200 mg/kg/day divided every 6-8 hours, with a maximum dose of 1500 mg per dose, according to the Journal of Microbiology, Immunology and Infection 1
- For neonates less than 7 days old, the recommended dose is 30 mg/kg IV every 12 hours, as stated by Clinical Infectious Diseases 2
- For neonates greater than 7 days old, the recommended dose is 30 mg/kg IV every 8 hours, as stated by Clinical Infectious Diseases 2
- For infants over 1 month, the recommended dose is 100-150 mg/kg/day divided every 6-8 hours, as recommended by the Journal of Microbiology, Immunology and Infection and Thorax 1, 3
Indication-Specific Dosing
- For complicated intra-abdominal infections, the recommended dose is 150 mg/kg/day divided every 6-8 hours, as stated by Clinical Infectious Diseases 4
- For bacterial meningitis, a dose of 200-240 mg/kg/day divided every 6-8 hours is recommended, although third-generation cephalosporins are generally preferred, according to Clinical Infectious Diseases 5
- For suspected MRSA infections, additional coverage with vancomycin or clindamycin is recommended, as stated by Clinical Infectious Diseases 5
- For patients with beta-lactam allergies, alternative agents should be considered based on the severity of the allergy, as recommended by Clinical Infectious Diseases 5
Oral Step-Down Therapy
- When switching to oral therapy, cefuroxime axetil can be used at a dose of 20-50 mg/kg/day divided every 12 hours (maximum 500 mg per dose), as stated by Thorax 3
Cefuroxime Pediatric Dosing Guidelines
Oral Dosing Recommendations
- For children 1-24 months, the American Academy of Pediatrics recommends 125 mg of cefuroxime axetil twice daily (oral) for the treatment of susceptible infections 6, 7
- For children 2-12 years, the American Academy of Pediatrics recommends 250 mg of cefuroxime axetil twice daily (oral) for the treatment of susceptible infections 6, 7
Adverse Effects and Monitoring of Intravenous Cefuroxime in Pediatric Patients
Gastrointestinal Effects
- In children receiving intravenous cefuroxime, mild gastrointestinal symptoms such as nausea, vomiting, abdominal pain, and diarrhea are reported. (Thorax 2007) 8
- Clinicians should monitor for signs of Clostridioides difficile infection in any pediatric patient who develops diarrhea during or after cefuroxime therapy. (Thorax 2007) 8
Hypersensitivity Reactions
- Cutaneous rash and other allergic manifestations may occur in pediatric patients treated with intravenous cefuroxime. (Thorax 2007) 8
Cefuroxime Oral Dosing and Clinical Considerations
Pediatric Dosing
- For children 1–24 months old, prescribe cefuroxime oral suspension 125 mg twice daily (every 12 h). 9
- For children 2–12 years old, prescribe cefuroxime oral suspension 250 mg twice daily (every 12 h). 9
Renal Function Adjustment
- In patients with creatinine clearance < 30 mL/min, reduce the oral cefuroxime dose by approximately 50 %, extrapolating from parenteral dosing recommendations. 9
Antimicrobial Spectrum
- Cefuroxime provides reliable activity against beta‑lactamase‑producing strains of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Moraxella catarrhalis, and common enteric gram‑negative bacteria. 9
Adverse‑Effect Monitoring
- The most frequent adverse effects are gastro‑intestinal symptoms (nausea, vomiting, abdominal discomfort, and diarrhea); these are usually mild and self‑limited, but any occurrence of diarrhea warrants evaluation for possible Clostridioides difficile infection. 9